Giving radiotherapy in fewer treatments but at higher doses could work just as well as standard regimes, but be cheaper and more convenient for patients.

The goal of our laboratory is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma, three paediatric solid tumours in which high-risk patient ...

Professor Peter Garland CBE, who served as Chief Executive of the ICR from 1989 to 1999, passed away on 5 March. He also played an important role as the Chair of Cambridge Antibody Technology (CAT) ...

The Institute of Cancer Research, London, is delighted to announce that Professor Paul Workman has been elected as a Fellow of The American Association for Cancer Research (AACR) Academy. The AACR, ...

The Centre for Cancer Drug Discovery at The Institute of Cancer Research, London, is the largest academic cancer drug discovery and development group worldwide. Its research groups cover every aspect ...

Dr Gabriela Kramer-Marek’s group uses cutting-edge biomedical imaging techniques to gain information about the way particular genes drive cancer progression. Our group’s long-term goal is to develop ...

The Terry Fox Run UK had its most successful year of fundraising ever in 2024, in no small part due to the generous support of multiple companies from far and wide. The grand total raised was £120,000 ...

Our group's aim is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma. The goal of our laboratory is to improve the treatment and survival of ...